Table 3.
Baseline characteristics of the study population
| Metabolic Syndrome | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Variables | Overall | Men | Women | ||||||
| Absent | Present | p | Absent | Present | p | Absent | Present | p | |
| n = 371 | n = 1043 | n = 260 | n = 490 | n = 111 | n = 553 | ||||
| Age (years) | 57.0 ± 10.3 | 56.1 ± 9.9 | 0.119 | 57.1 ± 10.5 | 56.8 ± 10.5 | 0.664 | 56.8 ± 9.8 | 55.4 ± 9.4 | 0.181 |
| HbA1C (%) | 8.3 ± 2.4 | 8.2 ± 2.1 | 0.366 | 8.3 ± 2.4 | 8.2 ± 2.1 | 0.475 | 8.2 ± 2.6 | 8.1 ± 2.1 | 0.687 |
| Duration of diabetes (years) | 6.6 ± 7.5 | 5.1 ± 5.7 | < 0.0001 | 7.1 ± 8.0 | 5.7 ± 6.0 | 0.008 | 5.5 ± 5.6 | 4.6 ± 5.3 | 0.084 |
| Total serum cholesterol (mg/dl) | 184.5 ± 40.9 | 187.2 ± 40.7 | 0.266 | 178.1 ± 38.4 | 183.2 ± 38.4 | 0.081 | 199.5 ± 42.8 | 190.8 ± 42.3 | 0.048 |
| Serum LDL cholesterol (mg/dl) | 113.2 ± 35.9 | 111.8 ± 35.2 | 0.506 | 106.8 ± 33.6 | 106.3 ± 33.8 | 0.845 | 128.2 ± 37.2 | 116.7 ± 35.8 | 0.002 |
| Serum Non HDL cholesterol (mg/dl) | 3.7 ± 1.0 | 3.8 ± 1.0 | 0.029 | 3.6 ± 0.9 | 3.8 ± 0.9 | 0.009 | 3.9 ± 1.0 | 3.9 ± 1.1 | 0.488 |
| Hemoglobin (gm/dl) | 13.8 ± 1.8 | 13.8 ± 1.4 | 0.884 | 14.2 ± 1.9 | 14.5 ± 1.4 | 0.013 | 12.7 ± 1.3 | 13.1 ± 1.1 | 0.003 |
HbA1C (%), Glycosylated hemoglobin; LDL, Low density lipoprotein; HDL, High-density lipoprotein